J. P. Allerton

Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial

Paul G. Richardson, J. Wolf, Andrzej Jakubowiak et al. · Journal of Clinical Oncology · 2011 · 119 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Rituximab with short duration chemotherapy followed by ⁹⁰Y ibritumomab tiuxetan as first-line treatment for patients with follicular lymphoma: Update of a Minnie Pearl Cancer Research Network phase II trial

Dianna Shipley, F. Anthony Greco, David R. Spigel et al. · Journal of Clinical Oncology · 2005 · 44 citations

Medicine, Oncology, Pharmacotherapy +15

A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

J. P. Allerton, Christopher Hagenstad, R. Timothy Webb et al. · Journal of Clinical Oncology · 2006 · 14 citations

Medicine, Oncology, Pharmacology +17